Publications
- Antiplatelet efficacy of P2Y12 inhibitors (prasugrel, ticagrelor, clopidogrel) in patients treated with mild therapeutic hypothermia after cardiac arrest due to acute myocardial infarction2016 | Third Faculty of Medicine, Faculty of Mathematics and Physics
- Antiplatelet effect of prasugrel and clopidogrel in hypothermic patients after cardiac arrest for acute myocardial infarction2014 | Third Faculty of Medicine, Faculty of Mathematics and Physics
- Pretreatment with Prasugrel in Non-ST-Segment Elevation Acute Coronary Syndromes2013 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Renal Function, Assessed Using Cystatin C, and Antiplatelet Efficacy of Clopidogrel Assessed Using the Vasodilator-Stimulated Phosphoprotein Index in Patients Having Percutaneous Coronary Intervention2012 | Third Faculty of Medicine
- Platelet gene polymorphisms and risk of bleeding in patients undergoing elective coronary angiography: A genetic substudy of the PRAGUE-8 trial2010 | First Faculty of Medicine, Third Faculty of Medicine
- Optimal pretreatment timing for high load dosing (600 mg) of clopidogrel before planned percutaneous coronary intervention for maximal antiplatelet effectiveness2010 | First Faculty of Medicine, Third Faculty of Medicine
- Clopidogrel Before Elective Percutaneous Coronary Intervention2010 | Third Faculty of Medicine
- A comparison of the VASP index between patients with hemodynamically complicated and uncomplicated acute myocardial infarction2010 | Third Faculty of Medicine
- Measuring of platelet activity and effi cacy of antiplatelet therapy2010 | Third Faculty of Medicine
- Antithrombotic therapy in patients at risk for coronary stent thrombosis undergoing non-cardiac surgery2010 | Third Faculty of Medicine
Loading network view...